Skip to content

Exercise Intervention for Multiple Sclerosis: the Sheffield ExIMS trial

The effects of a pragmatic exercise therapy intervention on physical activity and important health outcomes influencing maintenance in people with multiple sclerosis (PWMS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN41541516
Enrollment
120
Registered
2009-02-05
Start date
2009-01-01
Completion date
Unknown
Last updated
2018-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis Nervous System Diseases Multiple sclerosis

Interventions

Exercise Group: A 12-week intervention period is planned for the exercise group, with a more frequent contact phase during the first 6-week block (two supervised exercise sessions at the centre and o

Sponsors

Sheffield Teaching Hospitals NHS Foundation Trust (UK)
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Clinical diagnosis of MS with an Expanded Disability Status Scale (EDSS) score of between 1.0 - 6.5, and able to walk 10 m distance 2. Aged 18 - 65 years, either sex 3. Participants must have been clinically stable for at least 4 weeks prior to entering the study 4. Participants on disease modifying therapy (interferon and glatiramer acetate) must have been stable on this treatment for at least 3 months prior to entering the study 5. Physically able to participate in some form of exercise three times per week 6. Able to provide written informed consent

Exclusion criteria

Exclusion criteria: 1. Failure to meet any of the above inclusion criteria 2. Experiencing illness that impairs their ability to be physically active three times per week 3. Not willing to be randomised to either the exercise intervention or usual care control group 4. Living more than 20 miles from the trial centre 5. Already engaged in purposeful structured exercise or brisk walking exercise for equal to or greater than three times per week for equal to or greater than 30 minutes per session and have been so on a consistent basis during the previous six months

Design outcomes

Primary

MeasureTime frame
1. Physical activity levels 2. Six-minute walking test All outcome measures will be taken at baseline, 12-weeks and at 6-months follow-up.

Secondary

MeasureTime frame
1. Neurological impairment and clinical functional mobility 2. Quality of life 3. Fatigue 4. Focus groups and interviews 5. Immunological analysis All outcome measures will be taken at baseline, 12-weeks and at 6-months follow-up.

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Mar 4, 2026